AAM
INSM icon

Alphadyne Asset Management’s Insmed INSM Stock Holding History

Alphadyne Asset Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$346K Buy
2,119
+1,755
+482% +$270K 0.01% 738
2025
Q4 		$63.4K Buy
+364
New +$66.4K ﹤0.01% 807

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Alphadyne Asset Management's INSM Position: Q1 2026 in Review

Alphadyne Asset Management increased its Insmed (INSM) stake by 482% in Q1 2026, buying an estimated $270K and bringing the position to 2,119 shares worth $346K. The position accounts for 0.01% of the portfolio, ranked #738.

Alphadyne Asset Management first reported a position in INSM in Q4 2025 and has held it in 2 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Alphadyne Asset Management held 2,119 shares of Insmed worth $346K as of Q1 2026.
  • Alphadyne Asset Management bought 1,755 Insmed shares in Q1 2026, an estimated $270K.
  • Insmed made up 0.01% of Alphadyne Asset Management's portfolio in Q1 2026, its #738 holding.
  • Alphadyne Asset Management first reported a position in Insmed in Q4 2025 and has held it in 2 quarters since.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Alphadyne Asset Management's 13F filing for Q1 2026, filed 15 May 2026.